What Genes Reveal About Cannabis and Mental Health

Cannabis use is stepping into a new era of scientific scrutiny.  A recent large-scale genetic study¹ explores how gene variants influence both the tendency to use cannabis—and how often—and how these same genes overlap with traits like impulsivity, mood, and psychiatric risk.  That makes the question less about “Does cannabis cause mental illness?” and more about “For whom, under what conditions, and why?”

How Researchers Mapped the Genes Behind Cannabis Use

Researchers analyzed data from over 130,000 people who provided genetic information and answered questions about lifetime cannabis use and frequency.  Through genome-wide association studies (GWAS), they looked for DNA variants (so-called “loci”) that correlate with whether someone ever used cannabis, and how often.  They identified two key loci near the genes CADM2 and GRM3 as being strongly tied to use.

These variants showed modest heritability: about 12.9% of the variance in lifetime use and 6.6% in how often people use cannabis could be statistically explained by these genetic factors.  But crucially, the study also found that these gene signals overlap with many other traits—psychiatric conditions, cognitive traits, and some physical health outcomes.

How Genes Link Cannabis Use and Mental Health

Swipe to scroll →

The genes spotlighted—CADM2 and GRM3—aren’t random.  CADM2 is tied to nerve-cell communication and has been previously linked with impulsivity and behavioral traits.  GRM3 plays a role in glutamate signaling and has been implicated in psychiatric disorders such as schizophrenia.

Beyond that, the study observed that genetic risk for cannabis use overlaps significantly with risk for psychiatric disorders such as ADHD, depression, and schizophrenia.  Furthermore, when looking at cannabis use disorder (CUD, i.e., problematic use), the overlap with mental health traits was even more substantial, and there is evidence of bidirectional causal links.  In other words, pathways may run both ways: psychiatric vulnerability might increase the risk of cannabis misuse, and cannabis misuse might in turn exacerbate psychiatric risk.

Understanding What the Findings Really Mean

This kind of research helps us see patterns—who might be more vulnerable, what shared genetic “wiring” underlies both drug use and mental health traits—but it doesn’t prove cause and effect.  Just because a gene is linked with both cannabis use and depression doesn’t mean cannabis use causes depression in every person with that gene.  Environmental factors, life experiences, stress, trauma, and context play huge roles.

Also, the magnitudes are modest.  Genetic influences are just part of the puzzle, not the whole picture.  Many people with these gene variants never develop mental health problems, while others with few risk genes might still struggle.

How These Findings Compare With Other Cannabis Studies

These findings are consistent with growing evidence that heavy or high-THC cannabis use is more risky for mental health, particularly in susceptible individuals.  A systematic review recently linked high-concentration cannabis products with elevated rates of psychosis, addiction, and adverse psychiatric outcomes.

Other research has shown that frequent use of high-potency cannabis can leave epigenetic signatures—changes in DNA methylation—in genes tied to immune or mitochondrial function.  In effect, long-term use might leave molecular marks on one’s biology.

Finally, large genetic studies of cannabis use disorder itself show that CUD has distinct genetic patterns compared to casual cannabis use, and these patterns more strongly overlap with psychiatric disorders like schizophrenia.

What This Means for Individuals and Public Health

For someone considering cannabis use (or already using), these insights suggest that genetic predisposition matters.  If you carry specific risk variants, you might be more sensitive to downsides.  But genetics isn’t destiny.  Lifestyle, consumption patterns (how much, how often, potency), age at first use, and mental health history all matter a lot.

In public health terms, genetic data may one day help stratify risk—for example, identifying who might need more monitoring or education before engaging in heavier use.  It may also help guide prevention strategies as legalization spreads.

Practical Takeaways and Safer Use Guidance

• Be mindful of potency and frequency: Using high-THC products often is more likely to push someone into risk territory, especially if there’s genetic or psychiatric vulnerability.
• Avoid early heavy use, especially in adolescence, when the brain is still developing.
• If there is a personal or family history of conditions like schizophrenia, bipolar disorder, or severe mood disorders, extra caution is warranted.
• Genetic knowledge should not be taken as deterministic, but rather as one lens among many.

References:

^{1. Thorpe, H.H.A., Fontanillas, P., Meredith, J.J. et al. Genome-wide association studies of lifetime and frequency of cannabis use in 131,895 individuals. Mol Psychiatry (2025). https://doi.org/10.1038/s41380-025-03219-2}